Traws Pharma, Inc. Operating Expenses
Traws Pharma, Inc. (TRAW) reported Operating Expenses of $3.17 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-14
- Traws Pharma, Inc. operating expenses for the quarter ending 2026-06-30 was $3.17M, a 20.27% decline year-over-year.
- Traws Pharma, Inc. operating expenses for the quarter ending 2026-03-31 was $6.95M, a 32.05% increase year-over-year.
- Traws Pharma, Inc. operating expenses for the quarter ending 2025-12-31 was $7.37M, a 38.13% increase year-over-year.
- Traws Pharma, Inc. operating expenses for the quarter ending 2025-09-30 was $4.05M, a 52.81% decline year-over-year.
- Traws Pharma, Inc. operating expenses for fiscal 2025 was $20.66M, a 85.51% decline from fiscal 2024.
- Traws Pharma, Inc. operating expenses for fiscal 2024 was $142.60M, a 594.80% increase from fiscal 2023.
- Traws Pharma, Inc. operating expenses for fiscal 2023 was $20.52M, a 3.38% increase from fiscal 2022.
- Traws Pharma, Inc. operating expenses for fiscal 2022 was $19.85M, a 18.72% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.17M 10-Q · filed 2026-08-14 | $10.12M 10-Q · filed 2026-08-14 | $17.49M derived: sum of 3 quarters · filed 2026-08-14 | $21.54M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $6.95M 10-Q · filed 2026-05-15 | $14.31M derived: sum of 2 quarters · filed 2026-05-15 | $18.37M derived: sum of 3 quarters · filed 2026-05-15 | $22.35M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $7.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $11.42M derived: sum of 2 quarters · filed 2026-04-15 | $15.40M derived: sum of 3 quarters · filed 2026-08-14 | $20.66M 10-K · filed 2026-04-15 |
| 2025-09-30 | $4.05M 10-Q · filed 2025-11-13 | $8.04M derived: sum of 2 quarters · filed 2026-08-14 | $13.30M 10-Q · filed 2025-11-13 | $18.63M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $3.98M 10-Q · filed 2026-08-14 | $9.24M 10-Q · filed 2026-08-14 | $14.58M derived: sum of 3 quarters · filed 2026-08-14 | $23.17M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $5.26M 10-Q · filed 2026-05-15 | $10.59M derived: sum of 2 quarters · filed 2026-05-15 | $19.19M derived: sum of 3 quarters · filed 2026-05-15 | $142.59M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $5.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $13.93M derived: sum of 2 quarters · filed 2026-04-15 | $137.33M derived: sum of 3 quarters · filed 2026-04-15 | $142.60M 10-K · filed 2026-04-15 |
| 2024-09-30 | $8.59M 10-Q · filed 2025-11-13 | $132.00M derived: sum of 2 quarters · filed 2025-11-13 | $137.27M 10-Q · filed 2025-11-13 | $141.78M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $123.41M 10-Q · filed 2025-08-14 | $128.67M 10-Q · filed 2025-08-14 | $133.19M derived: sum of 3 quarters · filed 2025-08-14 | $138.34M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $5.27M 10-Q · filed 2025-05-15 | $9.79M derived: sum of 2 quarters · filed 2025-05-15 | $14.93M derived: sum of 3 quarters · filed 2025-05-15 | $19.60M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $4.52M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $9.66M derived: sum of 2 quarters · filed 2025-03-31 | $14.33M derived: sum of 3 quarters · filed 2025-03-31 | $20.52M 10-K · filed 2025-03-31 |
| 2023-09-30 | $5.15M 10-Q · filed 2024-11-14 | $9.81M derived: sum of 2 quarters · filed 2024-11-14 | $16.01M 10-Q · filed 2024-11-14 | $21.80M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $4.67M 10-Q · filed 2024-08-15 | $10.86M 10-Q · filed 2024-08-15 | $16.65M derived: sum of 3 quarters · filed 2024-08-15 | $22.35M derived: sum of 4 quarters · filed 2024-08-15 |
| 2023-03-31 | $6.19M 10-Q · filed 2024-05-15 | $11.98M derived: sum of 2 quarters · filed 2024-05-15 | $17.68M derived: sum of 3 quarters · filed 2024-05-15 | $21.86M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $5.79M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $11.49M derived: sum of 2 quarters · filed 2024-04-01 | $15.66M derived: sum of 3 quarters · filed 2024-04-01 | $19.85M 10-K · filed 2024-04-01 |
| 2022-09-30 | $5.70M 10-Q · filed 2023-11-14 | $9.88M derived: sum of 2 quarters · filed 2023-11-14 | $14.06M 10-Q · filed 2023-11-14 | $17.88M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $4.18M 10-Q · filed 2023-08-14 | $8.37M 10-Q · filed 2023-08-14 | $12.18M derived: sum of 3 quarters · filed 2023-08-14 | $16.23M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $4.19M 10-Q · filed 2023-05-15 | $8.01M derived: sum of 2 quarters · filed 2023-05-15 | $12.05M derived: sum of 3 quarters · filed 2023-05-15 | $16.76M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $3.82M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $7.87M derived: sum of 2 quarters · filed 2023-03-30 | $12.57M derived: sum of 3 quarters · filed 2023-03-30 | $16.72M 10-K · filed 2023-03-30 |
| 2021-09-30 | $4.05M 10-Q · filed 2022-11-14 | $8.75M derived: sum of 2 quarters · filed 2022-11-14 | $12.90M 10-Q · filed 2022-11-14 | $19.21M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $4.70M 10-Q · filed 2022-08-15 | $8.86M 10-Q · filed 2022-08-15 | $15.17M derived: sum of 3 quarters · filed 2022-08-15 | $21.51M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $4.15M 10-Q · filed 2022-05-13 | $10.47M derived: sum of 2 quarters · filed 2022-05-13 | $16.81M derived: sum of 3 quarters · filed 2022-05-13 | $24.20M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $6.31M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $12.65M derived: sum of 2 quarters · filed 2022-03-21 | $20.05M derived: sum of 3 quarters · filed 2022-03-21 | $25.22M 10-K · filed 2022-03-21 |
| 2020-09-30 | $6.34M 10-Q · filed 2021-11-15 | $13.73M derived: sum of 2 quarters · filed 2021-11-15 | $18.91M 10-Q · filed 2021-11-15 | $24.67M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $7.39M 10-Q · filed 2021-08-16 | $12.57M 10-Q · filed 2021-08-16 | $18.33M derived: sum of 3 quarters · filed 2021-08-16 | $23.49M derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $5.18M 10-Q · filed 2021-05-17 | $10.94M derived: sum of 2 quarters · filed 2021-05-17 | $16.10M derived: sum of 3 quarters · filed 2021-05-17 | $21.75M derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $5.76M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $10.92M derived: sum of 2 quarters · filed 2021-03-18 | $16.57M derived: sum of 3 quarters · filed 2021-03-18 | $23.88M 10-K · filed 2021-03-18 |
| 2019-09-30 | $5.16M 10-Q · filed 2020-11-16 | $10.82M derived: sum of 2 quarters · filed 2020-11-16 | $18.12M 10-Q · filed 2020-11-16 | $24.33M derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | $5.66M 10-Q · filed 2020-08-12 | $12.96M 10-Q · filed 2020-08-12 | $19.17M derived: sum of 3 quarters · filed 2020-08-12 | $24.88M derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | $7.31M 10-Q · filed 2020-05-15 | $13.52M derived: sum of 2 quarters · filed 2020-05-15 | $19.23M derived: sum of 3 quarters · filed 2020-05-15 | $25.35M derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | $6.21M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $11.92M derived: sum of 2 quarters · filed 2020-03-27 | $18.04M derived: sum of 3 quarters · filed 2020-03-27 | $24.51M 10-K · filed 2020-03-27 |
| 2018-09-30 | $5.71M 10-Q · filed 2018-11-14 | $11.84M derived: sum of 2 quarters · filed 2018-11-14 | $18.30M 10-Q · filed 2018-11-14 | $24.56M derived: sum of 4 quarters · filed 2019-05-15 |
| 2018-06-30 | $6.12M 10-Q · filed 2018-08-14 | $12.59M 10-Q · filed 2018-08-14 | $18.85M derived: sum of 3 quarters · filed 2019-05-15 | $25.72M derived: sum of 4 quarters · filed 2019-05-15 |
| 2018-03-31 | $6.47M 10-Q · filed 2019-05-15 | $12.73M derived: sum of 2 quarters · filed 2019-05-15 | $19.59M derived: sum of 3 quarters · filed 2019-05-15 | $25.99M derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | $6.26M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $13.13M derived: sum of 2 quarters · filed 2019-04-01 | $19.52M derived: sum of 3 quarters · filed 2019-04-01 | $26.52M 10-K · filed 2019-04-01 |
| 2017-09-30 | $6.87M 10-Q · filed 2018-11-14 | $13.26M derived: sum of 2 quarters · filed 2018-11-14 | $20.26M 10-Q · filed 2018-11-14 | $26.91M derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $6.39M 10-Q · filed 2018-08-14 | $13.39M 10-Q · filed 2018-08-14 | $20.04M derived: sum of 3 quarters · filed 2018-08-14 | $26.00M derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | $7.00M 10-Q · filed 2018-05-15 | $13.64M derived: sum of 2 quarters · filed 2018-05-15 | $19.61M derived: sum of 3 quarters · filed 2018-05-15 | $27.26M derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | $6.64M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $12.61M derived: sum of 2 quarters · filed 2018-03-16 | $20.26M derived: sum of 3 quarters · filed 2018-03-16 | $29.25M 10-K · filed 2018-03-16 |
| 2016-09-30 | $5.97M 10-Q · filed 2017-11-09 | $13.61M derived: sum of 2 quarters · filed 2017-11-09 | $22.61M 10-Q · filed 2017-11-09 | $28.99M derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-06-30 | $7.65M 10-Q · filed 2017-08-14 | $16.64M 10-Q · filed 2017-08-14 | $23.03M derived: sum of 3 quarters · filed 2017-08-14 | $30.53M derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | $8.99M 10-Q · filed 2017-05-15 | $15.38M derived: sum of 2 quarters · filed 2017-05-15 | $22.88M derived: sum of 3 quarters · filed 2017-05-15 | $31.96M derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | $6.39M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | $13.88M derived: sum of 2 quarters · filed 2017-03-29 | $22.96M derived: sum of 3 quarters · filed 2017-03-29 | $35.43M 10-K · filed 2017-03-29 |
| 2015-09-30 | $7.50M 10-Q · filed 2016-11-14 | $16.58M derived: sum of 2 quarters · filed 2016-11-14 | $29.04M 10-Q · filed 2016-11-14 | $42.52M derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | $9.08M 10-Q · filed 2016-08-15 | $21.54M 10-Q · filed 2016-08-15 | $35.02M derived: sum of 3 quarters · filed 2016-08-15 | $50.02M derived: sum of 4 quarters · filed 2016-08-15 |
| 2015-03-31 | $12.46M 10-Q · filed 2016-05-11 | $25.94M derived: sum of 2 quarters · filed 2016-05-11 | $40.94M derived: sum of 3 quarters · filed 2016-05-11 | $57.83M derived: sum of 4 quarters · filed 2016-05-11 |
| 2014-12-31 | $13.47M 10-K · filed 2015-03-30 | $28.48M derived: sum of 2 quarters · filed 2015-11-12 | $45.36M derived: sum of 3 quarters · filed 2015-11-12 | $64.54M 10-K · filed 2016-03-28 |
| 2014-09-30 | $15.00M 10-Q · filed 2015-11-12 | $31.89M derived: sum of 2 quarters · filed 2015-11-12 | $51.07M 10-Q · filed 2015-11-12 | $67.56M derived: sum of 4 quarters · filed 2015-11-12 |
| 2014-06-30 | $16.89M 10-Q · filed 2015-08-13 | $36.07M 10-Q · filed 2015-08-13 | $52.56M derived: sum of 3 quarters · filed 2015-08-13 | $73.78M derived: sum of 4 quarters · filed 2015-08-13 |
| 2014-03-31 | $19.18M 10-Q · filed 2015-05-15 | $35.67M derived: sum of 2 quarters · filed 2015-05-15 | $56.89M derived: sum of 3 quarters · filed 2015-05-15 | $70.05M derived: sum of 4 quarters · filed 2015-05-15 |
| 2013-12-31 | $16.49M 10-K · filed 2015-03-30 | $37.71M derived: sum of 2 quarters · filed 2015-03-30 | $50.87M derived: sum of 3 quarters · filed 2015-03-30 | $66.97M 10-K · filed 2015-03-30 |
| 2013-09-30 | $21.22M 10-K · filed 2015-03-30 | $34.38M derived: sum of 2 quarters · filed 2015-03-30 | $50.49M 10-Q · filed 2014-11-14 | $63.76M derived: sum of 4 quarters · filed 2015-03-30 |
| 2013-06-30 | $13.16M 10-K · filed 2015-03-30 | $29.27M 10-Q · filed 2014-08-14 | $42.54M derived: sum of 3 quarters · filed 2015-03-30 | $78.42M derived: sum of 4 quarters · filed 2015-03-30 |
| 2013-03-31 | $16.10M 10-K · filed 2015-03-30 | $29.38M derived: sum of 2 quarters · filed 2015-03-30 | $65.26M derived: sum of 3 quarters · filed 2015-03-30 | $73.66M derived: sum of 4 quarters · filed 2015-03-30 |
| 2012-12-31 | $13.27M 10-K · filed 2014-03-20 | $49.16M derived: sum of 2 quarters · filed 2014-03-20 | $57.56M derived: sum of 3 quarters · filed 2014-03-20 | $68.47M 10-K · filed 2015-03-30 |
| 2012-09-30 | $35.88M 10-K · filed 2014-03-20 | $44.29M derived: sum of 2 quarters · filed 2014-03-20 | $55.20M 10-Q · filed 2013-11-14 | |
| 2012-06-30 | $8.40M 10-K · filed 2014-03-20 | $19.31M 10-Q · filed 2013-09-06 | ||
| 2012-03-31 | $10.91M 10-K · filed 2014-03-20 | |||
| 2011-12-31 | $29.06M 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |